Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

OBJECTIVES: To assess the effectiveness and tolerability of dolutegravir (DTG)/lamivudine (3TC) among treatment-naive and virologically suppressed treatment-experienced individuals in the multicentre cohort of the Spanish HIV/AIDS Research Network (CoRIS) during the years 2018–2021. METHODS: We used...

Descripción completa

Detalles Bibliográficos
Autores principales: Suárez-García, Inés, Alejos, Belén, Hernando, Victoria, Viñuela, Laura, Vera García, Mar, Rial-Crestelo, David, Pérez Elías, María Jesús, Albendín Iglesias, Helena, Peraire, Joaquim, Tiraboschi, Juan, Díaz, Asunción, Moreno, Santiago, Jarrín, Inma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232237/
https://www.ncbi.nlm.nih.gov/pubmed/37099559
http://dx.doi.org/10.1093/jac/dkad102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232237/
https://www.ncbi.nlm.nih.gov/pubmed/37099559
http://dx.doi.org/10.1093/jac/dkad102

Ejemplares similares